Reinforced Pancreaticojejunostomy With or Without glubran2
Recruiting · NCT06756074 · Interventional (participants receive a specific treatment) · Lead sponsor: Minia University
View the official record on ClinicalTrials.gov →Interventions studied
Pancreaticojejunostomy without tissue adhesive glue modified cyanoacrylate (glubran 2)Reinforced pancreaticojejunostomy with tissue adhesive glue modified cyanoacrylate (glubran 2)
What this trial is about
Pancreatic fistula is one of the most serious complication after pancreatoduodenectomy. To reduce pancreatic fistula, many authors recommend different techniques in pancreatojejunostomy. The purpose of this study is to determine which is the best method in preventing pancreatic fistula by enforce pancreaticojejunostomy with tissue glue .
Who can take part
Age range
18 Years to 75 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 2
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- All the patients undergoing pancreaticoduodenectomy for cancer
- Patients able to give their informed consent
Exclusion criteria
- Unfit patients for surgery due to severe medical illness.
- Inoperable patients by imaging studies, irresectable tumors after laparotomy or diagnostic laparoscopy.
- Presence of distant metastasis .
- Patients refused to participate in the study.
Where it is running
1 location listed.
- Liver and GIT hospital / Minia university - Minya, Egypt